These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21321417)

  • 1. Visceral leishmaniasis: experimental models for drug discovery.
    Gupta S;
    Indian J Med Res; 2011 Jan; 133(1):27-39. PubMed ID: 21321417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.
    Jain SK; Sahu R; Walker LA; Tekwani BL
    J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds.
    Ravinder ; Bhaskar ; Gangwar S; Goyal N
    Curr Microbiol; 2012 Dec; 65(6):696-700. PubMed ID: 22945482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Leishmania donovani field isolates expressing the luciferase reporter gene in in vitro drug screening.
    Ashutosh ; Gupta S; Ramesh ; Sundar S; Goyal N
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3776-83. PubMed ID: 16131481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.
    Singh N; Gupta R; Jaiswal AK; Sundar S; Dube A
    J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and perspectives in Leishmania cell based drug-screening procedures.
    Sereno D; Cordeiro da Silva A; Mathieu-Daude F; Ouaissi A
    Parasitol Int; 2007 Mar; 56(1):3-7. PubMed ID: 17079188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.
    Jaiswal AK; Rao KB; Kushwaha P; Rawat K; Modukuri RK; Khare P; Joshi S; Mishra S; Rai A; Sashidhara KV; Dube A
    Int J Antimicrob Agents; 2016 Dec; 48(6):695-702. PubMed ID: 27876275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short report: fluorescent Leishmania: application to anti-leishmanial drug testing.
    Singh N; Dube A
    Am J Trop Med Hyg; 2004 Oct; 71(4):400-2. PubMed ID: 15516633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assay.
    Mandal S; Maharjan M; Ganguly S; Chatterjee M; Singh S; Buckner FS; Madhubala R
    Indian J Exp Biol; 2009 Jun; 47(6):475-9. PubMed ID: 19634714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani.
    Tegazzini D; Díaz R; Aguilar F; Peña I; Presa JL; Yardley V; Martin JJ; Coteron JM; Croft SL; Cantizani J
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3524-32. PubMed ID: 27021313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models for vaccine studies for visceral leishmaniasis.
    Garg R; Dube A
    Indian J Med Res; 2006 Mar; 123(3):439-54. PubMed ID: 16778322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of small molecule lead compounds for visceral leishmaniasis using a novel ex vivo splenic explant model system.
    Osorio Y; Travi BL; Renslo AR; Peniche AG; Melby PC
    PLoS Negl Trop Dis; 2011 Feb; 5(2):e962. PubMed ID: 21358812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of in vitro antileishmanial efficacy of cyclosporin A and its non-immunosuppressive derivative, dihydrocyclosporin A.
    Zheng ZW; Li J; Chen H; He JL; Chen QW; Zhang JH; Zhou Q; Chen DL; Chen JP
    Parasit Vectors; 2020 Feb; 13(1):94. PubMed ID: 32085719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect.
    Chauhan IS; Marwa S; Rao GS; Singh N
    Parasitol Res; 2020 Sep; 119(9):2991-3003. PubMed ID: 32748038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani.
    Kothari H; Kumar P; Sundar S; Singh N
    Parasitol Int; 2007 Mar; 56(1):77-80. PubMed ID: 17169604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N; Chatterjee M; Sundar S
    Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening.
    Lamotte S; Aulner N; Späth GF; Prina E
    Sci Rep; 2019 Jan; 9(1):438. PubMed ID: 30679614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chemical inhibitor of heat shock protein 78 (HSP78) from
    Das S; Banerjee A; Kamran M; Ejazi SA; Asad M; Ali N; Chakrabarti S
    J Biol Chem; 2020 Jul; 295(29):9934-9947. PubMed ID: 32471865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B inhibits entry of Leishmania donovani into primary macrophages.
    Paila YD; Saha B; Chattopadhyay A
    Biochem Biophys Res Commun; 2010 Aug; 399(3):429-33. PubMed ID: 20678487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.
    Zahid MSH; Johnson MM; Tokarski RJ; Satoskar AR; Fuchs JR; Bachelder EM; Ainslie KM
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():125-132. PubMed ID: 31493763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.